Blood clots form inside the heart when blood flow slows down, the heart’s inner lining is damaged, or the blood itself becomes more prone to clotting. These three conditions, sometimes present individually but often overlapping, account for nearly every case of intracardiac thrombosis. The most common triggers are atrial fibrillation, heart attacks, and heart failure, though mechanical heart valves and inherited clotting disorders also play a role.
Three Conditions That Allow Clots to Form
Every blood clot in the body, including those in the heart, traces back to one or more of three physiological problems: damage to the vessel or chamber wall, sluggish or stagnant blood flow, and a blood chemistry that clots too easily. In a healthy heart, blood moves through the chambers briskly enough that clotting factors never have time to accumulate and stick together. When something disrupts that flow, damages the tissue lining the chambers, or shifts the blood’s chemistry toward clotting, the conditions are right for a thrombus to form.
In practice, these three factors rarely act alone. A heart attack, for example, damages the heart wall while also weakening the muscle so blood pools in the chamber. That combination of injury and stagnation is far more dangerous than either one by itself.
Atrial Fibrillation: The Most Common Cause
Atrial fibrillation (AFib) is the single most frequent reason blood clots develop inside the heart. During AFib, the upper chambers quiver chaotically instead of contracting in a coordinated way. This means blood isn’t pushed out efficiently, and it pools in a small pouch called the left atrial appendage. The appendage’s shape and rough internal ridges make it especially prone to trapping stagnant blood.
In people with AFib, the flow pattern inside this pouch shifts to low-velocity, disorganized movement. Some patients lose any active emptying pattern altogether, which carries the highest risk of clot formation. If a clot forms here and breaks loose, it typically travels to the brain, causing a stroke. That’s why blood-thinning medication is a cornerstone of AFib management for people with additional stroke risk factors.
Heart Attacks and Heart Wall Damage
A heart attack kills a section of heart muscle, and the damaged area can become a breeding ground for clots. When the front wall of the left ventricle is affected (an anterior heart attack), the risk is particularly high. Estimates of how often a clot forms after this type of heart attack range from about 4% to 39%, depending on how quickly blood flow was restored, how large the damage was, and how soon imaging was performed.
The dead or scarred tissue no longer contracts, so blood swirls sluggishly around it. At the same time, the injured lining of the heart wall activates the clotting process directly. In some cases, the damaged area stretches outward into a permanent bulge called a ventricular aneurysm, which creates a pocket where blood can sit and clot indefinitely.
Clots after a heart attack most commonly form within the first two weeks but can appear up to several months later. When detected, anticoagulation therapy is typically started for about three months, with follow-up imaging to check whether the clot has resolved. The risk of a new clot forming remains elevated during that three-month window, so treatment usually isn’t stopped early even if imaging looks clear.
Heart Failure and Weak Pumping
Heart failure means the heart can’t pump blood as forcefully as it should. The less efficiently the heart contracts, the more blood lingers in the chambers. This stagnation is measured by ejection fraction, which represents the percentage of blood the left ventricle pushes out with each beat. A healthy heart ejects roughly 55% to 70%. When ejection fraction drops below 35%, the risk of a clot forming in the left ventricle rises significantly.
The clot typically forms at the apex, the very tip of the heart’s main pumping chamber, where blood velocity is lowest. People with severely reduced ejection fraction face not only a higher clot risk but also a greater chance of serious complications if that clot travels to the brain, kidneys, or limbs.
Mechanical Heart Valves
Artificial heart valves made of metal and carbon are durable, but their synthetic surfaces trigger the body’s clotting response. The annual incidence of a clot blocking a mechanical valve ranges from 0.3% to 1.3% per year, while broader clot-related complications (including clots that break off and travel elsewhere) occur at rates of 0.7% to 6% per year. Bioprosthetic valves, made from animal tissue, carry a much lower clotting risk by comparison.
Because of this, anyone with a mechanical heart valve takes blood thinners for life. Missing even a few days of medication can be enough for a clot to begin forming on the valve’s surface.
Inherited Clotting Disorders
Some people are genetically predisposed to form clots more easily. The best-studied mutation is Factor V Leiden, a change in one of the proteins involved in the clotting cascade that makes blood hypercoagulable. In one study of children with blood clots inside the heart, nearly half carried the Factor V Leiden mutation. Researchers recommend testing for this mutation in anyone who develops an intracardiac clot, even when another obvious cause is present, because the genetic tendency can amplify risk from other conditions.
Other inherited clotting disorders exist, including deficiencies in natural anticoagulant proteins your body produces. These conditions don’t guarantee a clot will form, but they lower the threshold, meaning it takes less stagnation or less tissue damage to tip the balance toward clotting.
Other Contributing Factors
Several additional conditions increase the likelihood of clots forming in the heart. Large areas of inflammation after open-heart surgery can damage the inner lining of the chambers. Certain cancers release substances that push blood toward a hypercoagulable state. Prolonged immobility after major illness or surgery slows circulation throughout the body, including through the heart’s chambers. Autoimmune conditions like antiphospholipid syndrome directly interfere with normal clotting regulation.
What a Heart Clot Feels Like
A blood clot sitting quietly inside the heart often causes no symptoms at all. Many are discovered incidentally during imaging for another condition. The danger comes when part or all of the clot breaks free and travels through the bloodstream. Where it lands determines what you feel.
If it reaches the brain, the result is a stroke: sudden weakness on one side of the body, slurred speech, or confusion. If it lodges in a lung artery, you may experience sharp chest pain and sudden shortness of breath. Clots that travel to limb arteries cause sudden pain, coldness, or numbness in an arm or leg. A clot that blocks a coronary artery triggers a heart attack, with crushing chest pain that may radiate to the jaw, shoulder, or arm.
Because the clot itself is often silent until it moves, the conditions that cause it (AFib, recent heart attack, severely reduced heart function) are treated as the warning signs. If you have one of these conditions, the goal of blood-thinning therapy is to prevent a clot from ever forming in the first place.